FDC Financial Statement Analysis
|
||
The Revenues of FDC have increased by 8.50% YoY .
The Earnings Per Share (EPS) of FDC has decreased by -12.54 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
FDC Last 5 Annual Financial Results
[BOM: 531599|NSE : FDC]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr |
Expenses | ₹1,783 Cr | ₹1,604 Cr | ₹1,534 Cr | ₹1,274 Cr | ₹999 Cr |
Operating Profit (Excl OI) | ₹325 Cr | ₹339 Cr | ₹250 Cr | ₹254 Cr | ₹334 Cr |
Other Income | ₹91 Cr | ₹102 Cr | ₹51 Cr | ₹76 Cr | ₹97 Cr |
Interest | ₹4.51 Cr | ₹4.03 Cr | ₹4.09 Cr | ₹3.09 Cr | ₹3.43 Cr |
Depreciation | ₹54 Cr | ₹40 Cr | ₹39 Cr | ₹37 Cr | ₹38 Cr |
Profit Before Tax | ₹357 Cr | ₹396 Cr | ₹258 Cr | ₹289 Cr | ₹388 Cr |
Profit After Tax | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr |
Consolidated Net Profit | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr |
Earnings Per Share (Rs) | ₹16.39 | ₹18.74 | ₹11.70 | ₹12.82 | ₹17.85 |
PAT Margin (%) | 12.26 | 15.26 | 10.54 | 13.74 | 22.06 |
ROE(%) | 12.19 | 14.96 | 9.84 | 11.71 | 18.36 |
ROCE(%) | 16.52 | 19.62 | 13.27 | 15.78 | 23.74 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 7,120.9 Cr |
Revenue (TTM) | : | ₹ 2,118.3 Cr |
Net Profit(TTM) | : | ₹ 269.1 Cr |
EPS (TTM) | : | ₹ 16.5 |
P/E (TTM) | : | 26.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
FDC | -2.1% | -6.9% | -22.8% |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% | 3.6% | -12.5% |
DIVIS LABORATORIES | 1% | 9.4% | 8% |
CIPLA | 0.9% | 1.2% | -0.2% |
TORRENT PHARMACEUTICALS | 1.7% | 1% | 1% |
DR REDDYS LABORATORIES | -0.5% | -4.2% | -6.3% |
MANKIND PHARMA | 1.5% | -3.5% | -10.6% |
ZYDUS LIFESCIENCES | -0.6% | -4.6% | -7% |
LUPIN | -1.6% | -4.5% | -13.3% |
FDC Revenues
[BOM: 531599|NSE : FDC]
Y-o-Y | 8.50 % |
5 Yr CAGR | 12.14 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹2,108 Cr | 8.50 | |
Mar2024 | ₹1,943 Cr | 8.92 | |
Mar2023 | ₹1,784 Cr | 16.74 | |
Mar2022 | ₹1,528 Cr | 14.61 | |
Mar2021 | ₹1,333 Cr | - |
FDC Operating Profit
[BOM: 531599|NSE : FDC]
Y-o-Y | -4.06 % |
5 Yr CAGR | -0.70 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹325 Cr | -4.06 | |
Mar2024 | ₹339 Cr | 35.64 | |
Mar2023 | ₹250 Cr | -1.61 | |
Mar2022 | ₹254 Cr | -24.06 | |
Mar2021 | ₹334 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -11.54 % |
5 Yr CAGR | -11.45 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 15.41% | -11.54 | |
Mar2024 | 17.42% | 24.52 | |
Mar2023 | 13.99% | -15.72 | |
Mar2022 | 16.6% | -33.76 | |
Mar2021 | 25.06% | - |
FDC Profit After Tax
[BOM: 531599|NSE : FDC]
Y-o-Y | -12.55 % |
5 Yr CAGR | -3.00 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹267 Cr | -12.55 | |
Mar2024 | ₹305 Cr | 57.22 | |
Mar2023 | ₹194 Cr | -10.33 | |
Mar2022 | ₹216 Cr | -28.19 | |
Mar2021 | ₹301 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -19.66 % |
5 Yr CAGR | -13.66 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 12.26 % | -19.66 | |
Mar2024 | 15.26 % | 44.78 | |
Mar2023 | 10.54 % | -23.29 | |
Mar2022 | 13.74 % | -37.72 | |
Mar2021 | 22.06 % | - |
FDC Earnings Per Share (EPS)
[BOM: 531599|NSE : FDC]
Y-o-Y | -12.54 % |
5 Yr CAGR | -2.11 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹16 | -12.54 | |
Mar2024 | ₹19 | 60.17 | |
Mar2023 | ₹12 | -8.74 | |
Mar2022 | ₹13 | -28.18 | |
Mar2021 | ₹18 | - |
FDC Return on Capital Employed (ROCE)
[BOM: 531599|NSE : FDC]
Y-o-Y | -15.80 % |
5 Yr CAGR | -8.67 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 16.52% | -15.80 | |
Mar2024 | 19.62% | 47.85 | |
Mar2023 | 13.27% | -15.91 | |
Mar2022 | 15.78% | -33.53 | |
Mar2021 | 23.74% | - |
FDC Share Price vs Sensex
Current Share Price | : | ₹437.4 |
Current MarketCap | : | ₹ 7,120.9 Cr |
Updated EOD on | : | Oct 17,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | -2.1% |
-6.9% |
-22.8% |
SENSEX | 1.8% |
1.9% |
2.4% |
FDC related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 0.5% | 0.3% | 0.6% |
BSE SMALLCAP | -0.6% | -2.3% | -6.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY TOTAL MARKET | 1.1% | 0.8% | -0.9% |
NIFTY MICROCAP 250 | -0.7% | -2.9% | -8.5% |
You may also like the below Video Courses
FAQ about FDC Financials
How the annual revenues of FDC have changed ?
The Revenues of FDC have increased by 8.50% YoY .
How the Earnings per Share (EPS) of FDC have changed?
The Earnings Per Share (EPS) of FDC has decreased by -12.54 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs